Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2003
05/07/2003EP1308168A1 Novel remedies for cancer
05/07/2003EP1308167A1 Antigen presenting vesicles
05/07/2003EP1307567A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
05/07/2003EP1307566A2 Mitogen activated kinase
05/07/2003EP1307565A2 Vaccination against host cell-associated herpesviruses
05/07/2003EP1307564A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/07/2003EP1307557A2 Endothelial cell expression patterns
05/07/2003EP1307553A2 Mammalian dna binding membrane-associated protein-encoding gene and uses
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307551A2 Human ion channels
05/07/2003EP1307550A1 Human 7tm protein receptors and polynucleotides encoding the same
05/07/2003EP1307546A2 Ampk-related serine/threonine kinase, designated snark
05/07/2003EP1307544A2 32132, a fucosyltransferase family member and uses therefor
05/07/2003EP1307540A2 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
05/07/2003EP1307537A1 Neospora caninum isolate
05/07/2003EP1307473A1 Purification of hbv antigens for use in vaccines
05/07/2003EP1307466A2 Immunological adjuvant compounds
05/07/2003EP1307230A2 Enhancement of development of oviparous species by in ovo feeding
05/07/2003EP1307225A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
05/07/2003EP1307224A2 Vaccines comprising outer membrane vesicles from gram negative bacteria
05/07/2003EP1307223A1 Parenteral vaccine formulations and uses thereof
05/07/2003EP1307222A2 Non-human animal models of tolerance to hepatitis c virus immunogens
05/07/2003EP1307221A2 Modified sialic acid vaccines
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307213A2 Chlorella preparations exhibiting immunomodulating properties
05/07/2003EP1307211A1 Immune mediators and related methods
05/07/2003EP1307189A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
05/07/2003EP1137433B1 Pharmaceutical compositions containing protein-disulfide isomerases
05/07/2003EP0877798B1 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
05/07/2003EP0836648B1 Recombinant mva virus, and the use thereof
05/07/2003EP0831790B1 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
05/07/2003EP0674526B1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
05/07/2003EP0669982B1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
05/07/2003EP0627940B1 Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors
05/07/2003CN1416471A Recombinant rhabdoviruses as Live-Viral vaccines for immunodoeficiency viruses
05/07/2003CN1416432A Use of CD25 binding molecules in triatment of inflammatory diseases of gastro-intestinal tract
05/07/2003CN1416352A Outer membrane vesicle (OMV) vaccine comprising N. Meningitidis serogroup B outer membrane
05/07/2003CN1416350A Novel method for down-regulation of amyloid
05/07/2003CN1107681C Compound of polypeptide as antigen of hepatitis B virus and heat shock protein and its application
05/07/2003CA2405849A1 Reagents for the simultaneous detection of hcv core antigens and antibodies
05/06/2003US6559294 Chlamydia pneumoniae polynucleotides and uses thereof
05/06/2003US6559287 Artificial glycoprotein for use in the treatment of immunological, arthritic, asthmatic, psoriasis, chronic obstructive pulmonary disorders, inflammatory bowel, osteoarthritic and viral disorders
05/06/2003US6559282 Induction of antibodies against leutenizing hormone releasing hormone in mammals; obtain mammal, administer modulator, monitor immune response, evaluate for prevention of infections
05/06/2003US6559176 A method for regulating the activity of an autoinducer-2 receptor comprising contacting an autoinducer-2 receptor with an AI-2 agonist or antagonist compound.
05/06/2003US6559121 Vaccines for the protection of cattle from psoroptic scabies
05/06/2003US6559120 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
05/06/2003US6558950 Nucleotide sequences coding polypeptide for use in the treatment of programed cell death defects
05/06/2003US6558932 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
05/06/2003US6558919 Nucleotide sequences coding polypeptide for use in the prevention and treatment of infections
05/06/2003US6558905 Diagnosing osteoporosis in humans; obtain tissue sample, extract nucleotide sequences, digest, incubate with marker probe, detect presence of preferential allele, presence of allele indicate osteoporosis
05/06/2003US6558898 Antibody for use in the treatment of viral diseases
05/06/2003US6558678 Good expression during growth in liquid medium in shake cultures; large scale production
05/06/2003US6558677 Native outer membrane vesicles having outer membrane proteins and lipopolysaccharides from neisseria genetically altered so that neisseria is unable to synthesize sialic acid
05/06/2003US6558676 Immunizing mammal with noninfectious material and isolating antibodies produced
05/06/2003US6558675 Mutant human hepatitis B viral strain and uses thereof
05/06/2003US6558674 Polynucleotide vaccine formulation against pathologies of the horse
05/06/2003US6558673 Polypeptide fragment derived from G protein of streptococcus which binds specifically to mammalian serum albumin; immuni-zation
05/06/2003US6558672 Methods of making recombinant disulfide-stabilized polypeptide fragments having binding specificity
05/06/2003US6558670 Saponin and immunostimulatory oligonucleotide
05/06/2003US6558668 Methods for detection and treatment of neural cancers
05/06/2003US6558663 Promoting tolerance and inhibiting natural killer cell mediated attack in human recipient to a swine graft
05/06/2003US6558662 Treatment of hematologic disorders
05/06/2003US6558661 Inhibiting binding of interferon-gamma to its native receptor
05/06/2003US6557296 Nucleic acid molecule or fragment thereof that encodes a truncated Nef protein comprising a nucleic acid sequence that encodes substantially the same sequence of amino acid residues 1 through 56 of an HIV-1 Nef protein; treatment of htlv
05/06/2003CA2153165C Recombinant anti-hiv antibody and process for preparing the same
05/06/2003CA2115060C Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
05/06/2003CA2091263C Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
05/06/2003CA2082160C Humanised and chimeric monoclonal antibodies
05/06/2003CA2080408C Artificial standard and control sera, processes for the preparation thereof and the use thereof
05/06/2003CA2031811C Toxoplasma gondii antigens, the preparation thereof and the use thereof
05/02/2003EP1306437A2 Delta opioid receptor genes
05/02/2003EP1306431A1 Tumor antigen
05/02/2003EP1306095A2 Methods and compositions for targeting the vasculature of solid tumors
05/02/2003EP1305741A1 Online media exchange
05/02/2003EP1305447A2 Nucleic acids and pathogenic e.coli proteins, and their uses
05/02/2003EP1305438A1 Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s)
05/02/2003EP1305435A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
05/02/2003EP1305425A2 Drug metabolizing enzymes
05/02/2003EP1305419A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
05/02/2003EP1305418A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
05/02/2003EP1305414A2 Modified cea and uses thereof
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305402A1 Lipo-viro-particle complexes, preparation method and uses
05/02/2003EP1305343A2 Peptides presented by cells
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305337A2 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders
05/02/2003EP1305336A2 Therapeutic anti-melanoma compounds
05/02/2003EP1305334A1 Urocortin proteins and uses thereof
05/02/2003EP1305332A2 Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid
05/02/2003EP1305045A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications
05/02/2003EP1305044A2 Qs-21 and il-12 as an adjuvant combination
05/02/2003EP1305043A2 Respiratory syncytial virus vaccine
05/02/2003EP1305042A1 Compositions and methods for treatment of mucosal infections
05/02/2003EP1305041A1 Medicament for the immunotherapy of malignant tumours
05/02/2003EP1305039A2 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
05/02/2003EP1223966B1 Use of gdnf for treating corneal defects
05/02/2003EP1071456B1 Vaccines with an ltb adjuvant
05/02/2003EP1025082B1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
05/02/2003EP0948544B1 Monovalent antibody fragments
05/02/2003EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
1 ... 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 ... 1823